Notably, INTS6 acts as a tumor suppressor by inhibiting the Wnt/β-catenin signaling pathway, thereby impeding HCC progression, whereas INTS8 enhances EMT via activation of the TGF-β pathway, promoting tumor aggressiveness [19,20]. The gene discussed is TGFB1; the disease is neoplasm.